Home › Companies › TransMedics Group, Inc. › 2025-2026

TransMedics Group, Inc. 2025-2026 Proxy Voting Records

Compiled from SEC Form N-PX filings and TransMedics Group, Inc.’s Form 8-K, filed 2026-05-21 (Item 5.07 on EDGAR). Page generated 04 October 2026.

12Reported items
433Asset managers
4,949Fund votes
2026-05-20Meeting date

Proxy season: 2023-2024 2024-2025 2025-2026

Explore TransMedics Group, Inc. in the interactive database Compare manager voting policies

Official 2025-2026 meeting results reported by TransMedics Group, Inc.

These tallies are TransMedics Group, Inc.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed 2026-05-21 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

TransMedics Group, Inc. — official shareholder meeting results, meeting held 2026-05-20
Ballot item	For	Against	Abstain	Withheld	Broker non-votes	Outcome
Elect Director: Waleed Hassanein, M.D	23,925,335	122,999	15,389	--	4,632,985	Majority: yes
Elect Director: James R. Tobin	23,594,322	453,100	16,301	--	4,632,985	Majority: yes
Elect Director: Edward M. Basile	22,395,787	1,651,466	16,470	--	4,632,985	Majority: yes
Elect Director: Thomas J. Gunderson	23,667,347	380,233	16,143	--	4,632,985	Majority: yes
Elect Director: Edwin M. Kania, Jr.	23,603,708	443,438	16,577	--	4,632,985	Majority: yes
Elect Director: Stephanie Lovell	23,932,921	111,757	19,045	--	4,632,985	Majority: yes
Elect Director: Merilee Raines	23,908,647	140,715	14,361	--	4,632,985	Majority: yes
Elect Director: David Weill, M.D.	23,842,978	204,717	16,028	--	4,632,985	Majority: yes
Proposal Two : The shareholders approved, on a non-binding advisory basis, the compensation paid to the Company's named executive officers, based on the following votes:	22,871,647	1,161,181	30,895	--	4,632,985	Majority: yes
Proposal Three : The shareholders approved the amendment to the Amended and Restated TransMedics Group, Inc. 2019 Stock Incentive Plan, based on the following votes:	17,265,369	6,758,882	39,472	--	4,632,985	Majority: yes

Source: TransMedics Group, Inc., Form 8-K, filed with the SEC on 2026-05-21 — read the filing on EDGAR.

How asset managers voted at the TransMedics Group, Inc. 2025-2026 meeting

Each item below shows how the 433 asset managers that disclosed a TransMedics Group, Inc. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of TransMedics Group, Inc.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.

1. To approve, on a non-binding advisory basis, the compensation paid to TransMedics' named executive officers.

SECTION 14A SAY-ON-PAY VOTESMajority of the votes cast: yes

Combines 8 wordings of this item as funds reported it.

95% Majority: yes · of votes cast

FOR 95%

FOR: 22,871,647AGAINST: 1,161,181

TransMedics Group, Inc.’s own tally for this item (“Proposal Two : The shareholders approved, on a non-binding advisory basis, the compensation paid to the Company's named executive officers, based on the following votes:”): 22,871,647 for, 1,161,181 against, per its Form 8-K filed 2026-05-21 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 34,560,911 outstanding shares: 66% for, 3% against (70% of the company cast a for/against vote).

The 429 asset managers below cast 96% of the shares they voted on this item FOR. Fund share totals are not shown for this item: fund-reported shares overlap across filings (an adviser and the funds it manages can each report the same shares), and here their sum exceeds the total votes cast at the meeting.

FOR 96%

FOR: 95.7%AGAINST: 4.2%ABSTAIN: 0.0%NOT VOTED: 0.1%

Largest asset managers voting on “To approve, on a non-binding advisory basis, the compensation paid to TransMedics' named executive officers.” at TransMedics Group, Inc., 2025-2026
Asset manager	For	Against	Vote
Fidelity	8,612,136	0	For
Vanguard	3,849,938	3	For
BlackRock	2,907,855	513	For
GEODE CAPITAL MANAGEMENT, LLC	815,520	0	For
NOMURA INVESTMENT MANAGEMENT BUSINESS TRUST	792,204	0	For
Invesco	0	679,780	Against
Capital Group	600,008	0	For
Charles Schwab	597,092	0	For
MUTUAL FUND SERIES TRUST	548,667	0	For
State Street	528,980	0	For
T. Rowe Price	484,277	0	For
Delaware/Macquarie	465,804	0	For
Goldman Sachs	405,334	0	For
Wellington	376,434	0	For
Hood River Capital Management LLC	349,774	0	For
DRIEHAUS CAPITAL MANAGEMENT LLC	272,829	0	For
Royce	244,380	0	For
PRINCIPAL GLOBAL INVESTORS	231,591	0	For
WASATCH ADVISORS LP	224,158	0	For
Northern Trust	216,386	0	For
RBB FUND, INC.	200,871	0	For
Jackson National	65,621	128,843	Against
WASATCH FUNDS TRUST	189,803	0	For
BAILLIE GIFFORD & CO LTD	188,804	0	For
Waddell & Reed	175,256	0	For

Showing the 25 largest of 429 asset managers. See all 429 in the interactive database.

2. To approve an amendment to the TransMedics Group, Inc.'s Amended and Restated 2019 Stock Incentive Plan to increase the maximum aggregate number of shares of common stock that may be issued pursuant to awards granted under the TransMedics Group, Inc. Amended and Restated 2019 Stock Incentive Plan by 2,750,000 shares and make certain other changes as set forth in the proxy statement.

COMPENSATIONMajority of the votes cast: yes

Combines 5 wordings of this item as funds reported it.

72% Majority: yes · of votes cast

FOR 72%AGAINST 28%

FOR: 17,265,369AGAINST: 6,758,882

TransMedics Group, Inc.’s own tally for this item (“Proposal Three : The shareholders approved the amendment to the Amended and Restated TransMedics Group, Inc. 2019 Stock Incentive Plan, based on the following votes:”): 17,265,369 for, 6,758,882 against, per its Form 8-K filed 2026-05-21 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 34,560,911 outstanding shares: 49.9% for, 20% against (70% of the company cast a for/against vote).

The 125 asset managers below cast 78% of the shares they voted on this item FOR (11,964,651 for, 3,375,277 against).

FOR 78%AGAINST 22%

FOR: 11,964,651 (78.0%)AGAINST: 3,375,277 (22.0%)ABSTAIN: 6,406 (0.0%)

Largest asset managers voting on “To approve an amendment to the TransMedics Group, Inc.'s Amended and Restated 2019 Stock Incentive Plan to inc” at TransMedics Group, Inc., 2025-2026
Asset manager	For	Against	Abstain	Vote
Fidelity	4,293,637	0	0	For
Vanguard	3,433,737	125,293	0	For
BlackRock	1,928,200	0	0	For
MUTUAL FUND SERIES TRUST	543,312	5,355	0	For
Delaware/Macquarie	0	465,804	0	Against
Capital Group	300,004	0	0	For
Charles Schwab	0	278,518	0	Against
Royce	0	241,460	0	Against
Invesco	223,018	0	0	For
Jackson National	128,843	65,621	0	For
WASATCH FUNDS TRUST	0	189,803	0	Against
T. Rowe Price	0	187,439	0	Against
Waddell & Reed	0	175,256	0	Against
Hartford	0	153,587	0	Against
RBB FUND, INC.	148,004	0	0	For
State Street	137,553	222	0	For
Lord Abbett	133,800	0	0	For
Bridge Builder Trust	6,406	120,035	0	Against
Principal	81,911	29,862	0	For
Manager Directed Portfolios	0	110,588	0	Against
Brighthouse	57,862	31,941	6,406	For
Columbia Threadneedle	80,605	0	0	For
Lincoln Financial	25,857	48,205	0	Against
Brown Capital Management Mutual Funds	0	71,349	0	Against
TIAA	70,737	0	0	For

Showing the 25 largest of 125 asset managers. See all 125 in the interactive database.

3. Election of Directors: David Weill, M.D.

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 4 wordings of this item as funds reported it.

99.1% Majority: yes · of votes cast

FOR 99.1%

FOR: 23,842,978AGAINST: 204,717

TransMedics Group, Inc.’s own tally for this item (“Elect Director: David Weill, M.D.”): 23,842,978 for, 204,717 against, per its Form 8-K filed 2026-05-21 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 34,560,911 outstanding shares: 69% for, 0.6% against (70% of the company cast a for/against vote).

The 122 asset managers below cast 99.9% of the shares they voted on this item FOR (15,332,634 for, 6,269 against).

FOR 99.9%

FOR: 15,332,634 (99.9%)AGAINST: 6,269 (0.0%)ABSTAIN: 6,406 (0.0%)

Largest asset managers voting on “Election of Directors: David Weill, M.D.” at TransMedics Group, Inc., 2025-2026
Asset manager	For	Against	Abstain	Vote
Fidelity	4,293,637	0	0	For
Vanguard	3,559,028	3	0	For
BlackRock	1,928,200	0	0	For
MUTUAL FUND SERIES TRUST	548,667	0	0	For
Delaware/Macquarie	465,804	0	0	For
Capital Group	300,004	0	0	For
Charles Schwab	278,518	0	0	For
Royce	241,460	0	0	For
Invesco	223,018	0	0	For
Jackson National	194,464	0	0	For
WASATCH FUNDS TRUST	189,803	0	0	For
T. Rowe Price	187,439	0	0	For
Waddell & Reed	175,256	0	0	For
Hartford	153,587	0	0	For
RBB FUND, INC.	148,004	0	0	For
State Street	137,775	0	0	For
Lord Abbett	133,800	0	0	For
Bridge Builder Trust	126,441	0	0	For
Principal	111,773	0	0	For
Manager Directed Portfolios	110,588	0	0	For
Brighthouse	89,803	0	6,406	For
Columbia Threadneedle	80,605	0	0	For
Lincoln Financial	74,062	0	0	For
Brown Capital Management Mutual Funds	71,349	0	0	For
TIAA	70,737	0	0	For

Showing the 25 largest of 122 asset managers. See all 122 in the interactive database.

4. Election of Directors: Edward M. Basile

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 3 wordings of this item as funds reported it.

93% Majority: yes · of votes cast

FOR 93%

FOR: 22,395,787AGAINST: 1,651,466

TransMedics Group, Inc.’s own tally for this item (“Elect Director: Edward M. Basile”): 22,395,787 for, 1,651,466 against, per its Form 8-K filed 2026-05-21 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 34,560,911 outstanding shares: 65% for, 5% against (70% of the company cast a for/against vote).

The 122 asset managers below cast 94% of the shares they voted on this item FOR (14,469,628 for, 849,275 against).

FOR 94%

FOR: 14,469,628 (94.4%)AGAINST: 849,275 (5.5%)ABSTAIN: 6,406 (0.0%)

Largest asset managers voting on “Election of Directors: Edward M. Basile” at TransMedics Group, Inc., 2025-2026
Asset manager	For	Against	Abstain	Vote
Fidelity	4,293,637	0	0	For
Vanguard	3,554,077	4,954	0	For
BlackRock	1,928,200	0	0	For
MUTUAL FUND SERIES TRUST	548,667	0	0	For
Delaware/Macquarie	0	465,804	0	Against
Capital Group	300,004	0	0	For
Charles Schwab	278,518	0	0	For
Royce	241,460	0	0	For
Invesco	223,018	0	0	For
Jackson National	194,464	0	0	For
WASATCH FUNDS TRUST	189,803	0	0	For
T. Rowe Price	187,439	0	0	For
Waddell & Reed	0	175,256	0	Against
Hartford	153,587	0	0	For
RBB FUND, INC.	148,004	0	0	For
State Street	137,775	0	0	For
Lord Abbett	133,800	0	0	For
Bridge Builder Trust	126,441	0	0	For
Principal	111,773	0	0	For
Manager Directed Portfolios	110,588	0	0	For
Brighthouse	89,803	0	6,406	For
Columbia Threadneedle	0	80,605	0	Against
Lincoln Financial	38,860	35,202	0	For
Brown Capital Management Mutual Funds	71,349	0	0	For
TIAA	70,737	0	0	For

Showing the 25 largest of 122 asset managers. See all 122 in the interactive database.

5. Election of Directors: Edwin M. Kania, Jr.

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 3 wordings of this item as funds reported it.

98% Majority: yes · of votes cast

FOR 98%

FOR: 23,603,708AGAINST: 443,438

TransMedics Group, Inc.’s own tally for this item (“Elect Director: Edwin M. Kania, Jr.”): 23,603,708 for, 443,438 against, per its Form 8-K filed 2026-05-21 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 34,560,911 outstanding shares: 68% for, 1% against (70% of the company cast a for/against vote).

The 122 asset managers below cast 99.8% of the shares they voted on this item FOR (15,292,482 for, 26,421 against).

FOR 99.7%

FOR: 15,292,482 (99.8%)AGAINST: 26,421 (0.2%)ABSTAIN: 6,406 (0.0%)

Largest asset managers voting on “Election of Directors: Edwin M. Kania, Jr.” at TransMedics Group, Inc., 2025-2026
Asset manager	For	Against	Abstain	Vote
Fidelity	4,293,637	0	0	For
Vanguard	3,559,028	3	0	For
BlackRock	1,928,200	0	0	For
MUTUAL FUND SERIES TRUST	548,667	0	0	For
Delaware/Macquarie	465,804	0	0	For
Capital Group	300,004	0	0	For
Charles Schwab	278,518	0	0	For
Royce	241,460	0	0	For
Invesco	223,018	0	0	For
Jackson National	194,464	0	0	For
WASATCH FUNDS TRUST	189,803	0	0	For
T. Rowe Price	187,439	0	0	For
Waddell & Reed	175,256	0	0	For
Hartford	153,587	0	0	For
RBB FUND, INC.	148,004	0	0	For
State Street	137,765	10	0	For
Lord Abbett	133,800	0	0	For
Bridge Builder Trust	126,441	0	0	For
Principal	111,773	0	0	For
Manager Directed Portfolios	110,588	0	0	For
Brighthouse	89,803	0	6,406	For
Columbia Threadneedle	80,605	0	0	For
Lincoln Financial	74,062	0	0	For
Brown Capital Management Mutual Funds	71,349	0	0	For
TIAA	70,737	0	0	For

Showing the 25 largest of 122 asset managers. See all 122 in the interactive database.

6. Election of Directors: James R. Tobin

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 3 wordings of this item as funds reported it.

98% Majority: yes · of votes cast

FOR 98%

FOR: 23,594,322AGAINST: 453,100

TransMedics Group, Inc.’s own tally for this item (“Elect Director: James R. Tobin”): 23,594,322 for, 453,100 against, per its Form 8-K filed 2026-05-21 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 34,560,911 outstanding shares: 68% for, 1% against (70% of the company cast a for/against vote).

The 122 asset managers below cast 99.8% of the shares they voted on this item FOR (15,297,356 for, 21,546 against).

FOR 99.8%

FOR: 15,297,356 (99.8%)AGAINST: 21,546 (0.1%)ABSTAIN: 6,406 (0.0%)

Largest asset managers voting on “Election of Directors: James R. Tobin” at TransMedics Group, Inc., 2025-2026
Asset manager	For	Against	Abstain	Vote
Fidelity	4,293,637	0	0	For
Vanguard	3,554,086	4,945	0	For
BlackRock	1,928,200	0	0	For
MUTUAL FUND SERIES TRUST	548,667	0	0	For
Delaware/Macquarie	465,804	0	0	For
Capital Group	300,004	0	0	For
Charles Schwab	278,518	0	0	For
Royce	241,460	0	0	For
Invesco	223,018	0	0	For
Jackson National	194,464	0	0	For
WASATCH FUNDS TRUST	189,803	0	0	For
T. Rowe Price	187,439	0	0	For
Waddell & Reed	175,256	0	0	For
Hartford	153,587	0	0	For
RBB FUND, INC.	148,004	0	0	For
State Street	137,765	10	0	For
Lord Abbett	133,800	0	0	For
Bridge Builder Trust	126,441	0	0	For
Principal	111,773	0	0	For
Manager Directed Portfolios	110,588	0	0	For
Brighthouse	89,803	0	6,406	For
Columbia Threadneedle	80,605	0	0	For
Lincoln Financial	74,062	0	0	For
Brown Capital Management Mutual Funds	71,349	0	0	For
TIAA	70,737	0	0	For

Showing the 25 largest of 122 asset managers. See all 122 in the interactive database.

7. Election of Directors: Merilee Raines

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 3 wordings of this item as funds reported it.

99.4% Majority: yes · of votes cast

FOR 99.4%

FOR: 23,908,647AGAINST: 140,715

TransMedics Group, Inc.’s own tally for this item (“Elect Director: Merilee Raines”): 23,908,647 for, 140,715 against, per its Form 8-K filed 2026-05-21 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 34,560,911 outstanding shares: 69% for, 0.5% against (70% of the company cast a for/against vote).

The 122 asset managers below cast 99.8% of the shares they voted on this item FOR (15,312,671 for, 26,232 against).

FOR 99.7%

FOR: 15,312,671 (99.8%)AGAINST: 26,232 (0.2%)ABSTAIN: 6,406 (0.0%)

Largest asset managers voting on “Election of Directors: Merilee Raines” at TransMedics Group, Inc., 2025-2026
Asset manager	For	Against	Abstain	Vote
Fidelity	4,293,637	0	0	For
Vanguard	3,559,029	2	0	For
BlackRock	1,928,200	0	0	For
MUTUAL FUND SERIES TRUST	548,667	0	0	For
Delaware/Macquarie	465,804	0	0	For
Capital Group	300,004	0	0	For
Charles Schwab	278,518	0	0	For
Royce	241,460	0	0	For
Invesco	223,018	0	0	For
Jackson National	194,464	0	0	For
WASATCH FUNDS TRUST	189,803	0	0	For
T. Rowe Price	187,439	0	0	For
Waddell & Reed	175,256	0	0	For
Hartford	153,587	0	0	For
RBB FUND, INC.	148,004	0	0	For
State Street	137,775	0	0	For
Lord Abbett	133,800	0	0	For
Bridge Builder Trust	126,441	0	0	For
Principal	111,773	0	0	For
Manager Directed Portfolios	110,588	0	0	For
Brighthouse	89,803	0	6,406	For
Columbia Threadneedle	80,605	0	0	For
Lincoln Financial	74,062	0	0	For
Brown Capital Management Mutual Funds	71,349	0	0	For
TIAA	70,737	0	0	For

Showing the 25 largest of 122 asset managers. See all 122 in the interactive database.

8. Election of Directors: Stephanie Lovell

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 3 wordings of this item as funds reported it.

99.5% Majority: yes · of votes cast

FOR 99.5%

FOR: 23,932,921AGAINST: 111,757

TransMedics Group, Inc.’s own tally for this item (“Elect Director: Stephanie Lovell”): 23,932,921 for, 111,757 against, per its Form 8-K filed 2026-05-21 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 34,560,911 outstanding shares: 69% for, 0.4% against (70% of the company cast a for/against vote).

The 122 asset managers below cast 99.9% of the shares they voted on this item FOR (15,336,123 for, 2,780 against).

FOR 99.9%

FOR: 15,336,123 (99.9%)AGAINST: 2,780 (0.0%)ABSTAIN: 6,406 (0.0%)

Largest asset managers voting on “Election of Directors: Stephanie Lovell” at TransMedics Group, Inc., 2025-2026
Asset manager	For	Against	Abstain	Vote
Fidelity	4,293,637	0	0	For
Vanguard	3,559,029	2	0	For
BlackRock	1,928,200	0	0	For
MUTUAL FUND SERIES TRUST	548,667	0	0	For
Delaware/Macquarie	465,804	0	0	For
Capital Group	300,004	0	0	For
Charles Schwab	278,518	0	0	For
Royce	241,460	0	0	For
Invesco	223,018	0	0	For
Jackson National	194,464	0	0	For
WASATCH FUNDS TRUST	189,803	0	0	For
T. Rowe Price	187,439	0	0	For
Waddell & Reed	175,256	0	0	For
Hartford	153,587	0	0	For
RBB FUND, INC.	148,004	0	0	For
State Street	137,775	0	0	For
Lord Abbett	133,800	0	0	For
Bridge Builder Trust	126,441	0	0	For
Principal	111,773	0	0	For
Manager Directed Portfolios	110,588	0	0	For
Brighthouse	89,803	0	6,406	For
Columbia Threadneedle	80,605	0	0	For
Lincoln Financial	74,062	0	0	For
Brown Capital Management Mutual Funds	71,349	0	0	For
TIAA	70,737	0	0	For

Showing the 25 largest of 122 asset managers. See all 122 in the interactive database.

9. Election of Directors: Thomas J. Gunderson

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 3 wordings of this item as funds reported it.

98% Majority: yes · of votes cast

FOR 98%

FOR: 23,667,347AGAINST: 380,233

TransMedics Group, Inc.’s own tally for this item (“Elect Director: Thomas J. Gunderson”): 23,667,347 for, 380,233 against, per its Form 8-K filed 2026-05-21 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 34,560,911 outstanding shares: 68% for, 1% against (70% of the company cast a for/against vote).

The 122 asset managers below cast 99.8% of the shares they voted on this item FOR (15,292,492 for, 26,411 against).

FOR 99.7%

FOR: 15,292,492 (99.8%)AGAINST: 26,411 (0.2%)ABSTAIN: 6,406 (0.0%)

Largest asset managers voting on “Election of Directors: Thomas J. Gunderson” at TransMedics Group, Inc., 2025-2026
Asset manager	For	Against	Abstain	Vote
Fidelity	4,293,637	0	0	For
Vanguard	3,559,028	3	0	For
BlackRock	1,928,200	0	0	For
MUTUAL FUND SERIES TRUST	548,667	0	0	For
Delaware/Macquarie	465,804	0	0	For
Capital Group	300,004	0	0	For
Charles Schwab	278,518	0	0	For
Royce	241,460	0	0	For
Invesco	223,018	0	0	For
Jackson National	194,464	0	0	For
WASATCH FUNDS TRUST	189,803	0	0	For
T. Rowe Price	187,439	0	0	For
Waddell & Reed	175,256	0	0	For
Hartford	153,587	0	0	For
RBB FUND, INC.	148,004	0	0	For
State Street	137,775	0	0	For
Lord Abbett	133,800	0	0	For
Bridge Builder Trust	126,441	0	0	For
Principal	111,773	0	0	For
Manager Directed Portfolios	110,588	0	0	For
Brighthouse	89,803	0	6,406	For
Columbia Threadneedle	80,605	0	0	For
Lincoln Financial	74,062	0	0	For
Brown Capital Management Mutual Funds	71,349	0	0	For
TIAA	70,737	0	0	For

Showing the 25 largest of 122 asset managers. See all 122 in the interactive database.

10. Election of Directors: Waleed H. Hassanein, M.D.

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 4 wordings of this item as funds reported it.

99.4% Majority: yes · of votes cast

FOR 99.4%

FOR: 23,925,335AGAINST: 122,999

TransMedics Group, Inc.’s own tally for this item (“Elect Director: Waleed Hassanein, M.D”): 23,925,335 for, 122,999 against, per its Form 8-K filed 2026-05-21 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 34,560,911 outstanding shares: 69% for, 0.4% against (70% of the company cast a for/against vote).

The 122 asset managers below cast 99.9% of the shares they voted on this item FOR (15,318,897 for, 5 against).

FOR 99.9%

FOR: 15,318,897 (100.0%)AGAINST: 5 (0.0%)ABSTAIN: 6,406 (0.0%)

Largest asset managers voting on “Election of Directors: Waleed H. Hassanein, M.D.” at TransMedics Group, Inc., 2025-2026
Asset manager	For	Against	Abstain	Vote
Fidelity	4,293,637	0	0	For
Vanguard	3,559,031	0	0	For
BlackRock	1,928,200	0	0	For
MUTUAL FUND SERIES TRUST	548,667	0	0	For
Delaware/Macquarie	465,804	0	0	For
Capital Group	300,004	0	0	For
Charles Schwab	278,518	0	0	For
Royce	241,460	0	0	For
Invesco	223,018	0	0	For
Jackson National	194,464	0	0	For
WASATCH FUNDS TRUST	189,803	0	0	For
T. Rowe Price	187,439	0	0	For
Waddell & Reed	175,256	0	0	For
Hartford	153,587	0	0	For
RBB FUND, INC.	148,004	0	0	For
State Street	137,770	5	0	For
Lord Abbett	133,800	0	0	For
Bridge Builder Trust	126,441	0	0	For
Principal	111,773	0	0	For
Manager Directed Portfolios	110,588	0	0	For
Brighthouse	89,803	0	6,406	For
Columbia Threadneedle	80,605	0	0	For
Lincoln Financial	74,062	0	0	For
Brown Capital Management Mutual Funds	71,349	0	0	For
TIAA	70,737	0	0	For

Showing the 25 largest of 122 asset managers. See all 122 in the interactive database.

11. To ratify the appointment of PricewaterhouseCoopers LLP as TransMedics Group, Inc.'s independent registered public accounting firm for the fiscal year ending December 31, 2026.

AUDIT-RELATED

Combines 2 wordings of this item as funds reported it.

99.8% fund support · no official result

FOR 99.7%

The 119 asset managers below cast 99.8% of the shares they voted on this item FOR (15,214,782 for, 28,379 against).

FOR: 15,214,782 (99.8%)AGAINST: 28,379 (0.2%)ABSTAIN: 6,406 (0.0%)

Largest asset managers voting on “To ratify the appointment of PricewaterhouseCoopers LLP as TransMedics Group, Inc.'s independent registered pu” at TransMedics Group, Inc., 2025-2026
Asset manager	For	Against	Vote
Fidelity	4,293,637	0	For
Vanguard	3,554,086	4,945	For
BlackRock	1,928,200	0	For
MUTUAL FUND SERIES TRUST	548,667	0	For
Delaware/Macquarie	465,804	0	For
Capital Group	300,004	0	For
Charles Schwab	278,518	0	For
Royce	241,460	0	For
Invesco	223,018	0	For
Jackson National	194,464	0	For
WASATCH FUNDS TRUST	189,803	0	For
T. Rowe Price	187,439	0	For
Waddell & Reed	175,256	0	For
Hartford	153,587	0	For
RBB FUND, INC.	148,004	0	For
State Street	137,765	10	For
Lord Abbett	133,800	0	For
Bridge Builder Trust	126,441	0	For
Principal	111,773	0	For
Manager Directed Portfolios	110,588	0	For
Columbia Threadneedle	80,605	0	For
Lincoln Financial	74,062	0	For
Brown Capital Management Mutual Funds	71,349	0	For
TIAA	70,737	0	For
Principal Exchange-Traded Funds	64,208	0	For

Showing the 25 largest of 119 asset managers. See all 119 in the interactive database.

12. Ratify PricewaterhouseCoopers LLP as Auditors

AUDIT-RELATED

95% fund support · no official result

FOR 95%

The 5 asset managers below cast 95% of the shares they voted on this item FOR (87,503 for, 4,438 against).

FOR: 87,503 (95.2%)AGAINST: 4,438 (4.8%)

Largest asset managers voting on “Ratify PricewaterhouseCoopers LLP as Auditors” at TransMedics Group, Inc., 2025-2026
Asset manager	For	Against	Vote
Brighthouse	57,862	0	For
Empower	24,916	0	For
VALUED ADVISERS TRUST	0	4,438	Against
CLEARWATER INVESTMENT TRUST	4,100	0	For
FORUM FUNDS	625	0	For

Largest TransMedics Group, Inc. shareholders voting in 2025-2026

Ranked by the number of TransMedics Group, Inc. shares each manager voted on the most widely held ballot item of the 2025-2026 meeting, shown as a share of the 34,560,911 shares outstanding at the time of that meeting.

Top TransMedics Group, Inc. shareholders by shares voted, 2025-2026
#	Asset manager	% of shares outstanding
1	Fidelity	24.92%
2	Vanguard	11.14%
3	BlackRock	8.42%
4	GEODE CAPITAL MANAGEMENT, LLC	2.36%
5	NOMURA INVESTMENT MANAGEMENT BUSINESS TRUST	2.29%
6	Invesco	1.97%
7	Capital Group	1.74%
8	Charles Schwab	1.73%
9	MUTUAL FUND SERIES TRUST	1.59%
10	State Street	1.53%

Reported TransMedics Group, Inc. ownership

Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).

TransMedics Group, Inc. beneficial owners on record for the 2025-2026 proxy season
Holder	% outstanding	Disclosure
BlackRock	15.32%	13F
FMR (Fidelity)	14.75%	13F
FMR LLC	14.64%	DEF14A
Vanguard Portfolio Management	5.64%	13G
Waleed H. Hassanein, M.D.	4.33%	DEF14A
State Street	3.82%	13F
Invesco	3.00%	13F
Goldman Sachs	2.51%	13F
Morgan Stanley	1.93%	13F
Dimensional Fund Advisors	1.49%	13F

Percentages above are of 34,560,911 shares outstanding, as reported by TransMedics Group, Inc. on its Form 10-Q dated 2026-04-30 (see the filing on EDGAR). This is the count contemporaneous with the 2025-2026 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from TransMedics Group, Inc.’s 10-Q dated 2026-04-30. This page is a static snapshot rebuilt weekly on 04 October 2026; a live search always shows the current data.

At TransMedics Group, Inc.'s shareholder meeting held 2026-05-20, in the 2025-2026 proxy season, 433 asset managers reported how they voted in their SEC Form N-PX filings, covering 4,949 separate fund positions. Their filings are grouped here into 12 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — To approve, on a non-binding advisory basis, the compensation paid to TransMedics' named… — FOR was 95% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: TransMedics Group, Inc.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on 2026-05-21.

TransMedics Group, Inc. proxy season coverage: 2023-2024 · 2024-2025 · 2025-2026 (this page).